Patent: 6,518,239
✉ Email this page to a colleague
Summary for Patent: 6,518,239
Title: | Dry powder compositions having improved dispersivity |
Abstract: | The present invention provides a highly dispersible formulation comprising an active agent and a dipeptide or tripeptide comprising at least two leucyl residues. The composition of the invention possesses superior aerosol properties and is thus preferred for aerosolized administration to the lung. Also provided are a method for (i) increasing the dispersibility of an active-agent containing formulation for administration to the lung, and (ii) delivery of the composition to the lungs of a subject. |
Inventor(s): | Kuo; Mei-Chang (Palo Alto, CA), Lechuga-Ballesteros; David (Santa Clara, CA) |
Assignee: | Inhale Therapeutic Systems, Inc. (San Carlos, CA) |
Application Number: | 09/548,759 |
Patent Claims: | see list of patent claims |
Details for Patent 6,518,239
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | 05/23/1994 | ⤷ Try a Trial | 2019-10-29 |
Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | 09/22/1999 | ⤷ Try a Trial | 2019-10-29 |
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2019-10-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |